Genedrive Share Discussion Threads

[hazl] 30/1/2021 18:13

Not exactly connected except for the danger of the virus in these places but nonetheless worrying.
What has happened to Britain?

'in an interview with the Guardian, he said: “I really feel like they’re trying to clamp down on the freedom of the press. The government is cracking down on people who are saying things they don’t want them to say, and that’s not right.”

[amaretto1] 30/1/2021 16:12

For any future outbreaks.

[hooded claw] 30/1/2021 13:32

I like the words "material and substancial" , towards the end of the interview, and starts in just a few weeks

[hazl] 29/1/2021 20:38

I like the word 'commercial'.


This company was 200p last year and that was without this piece of good news.

[hazl] 29/1/2021 17:26

Expect plenty of price action leading upto February.

Oh hold on we are the 29th of January!
Not long to wait.



'We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."

The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations. '

[justtrying1] 29/1/2021 17:04

1.5m sell at 59pExpect drop on monday

[jackdaw4243] 29/1/2021 16:37

Yes, but is the good news already factored in. I am holding on the basis more good news will come.

[rv2] 29/1/2021 15:34

The good news not reflecting on todays performance

[bunz3] 29/1/2021 13:34

read the rest of rns


well done to gdr

[bunz3] 29/1/2021 13:33

have a read at yesterdays rns

Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing



genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has entered into a distribution agreement with Beckman Coulter Life Sciences ("Beckman Coulter") for its Genedrive® 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive's high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory viral samples. The agreement is the result of the collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter's Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit.



The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing.

[ammu12] 29/1/2021 13:30

Another ramped shyte

[bunz3] 29/1/2021 13:22

longerterm hold for me this now after yesterdays rns

us market as well as Europe ,


some others look happy to take profits



I plant keep adding to my holding ,d y o r

[hazl] 29/1/2021 13:19

It's more about the general markets now and that's why the posters above feel its safer to come out again.

[andymunchkin] 29/1/2021 13:10

WhatsGonna happen whenHe goesIn dumpPhase

[andymunchkin] 29/1/2021 13:09

Bunzr isHyperPump phase

[billthebank] 29/1/2021 13:01

Just tweeted them as havent seen a statement from Beckman Coulter

[bunz3] 29/1/2021 12:01

next two weeks how high is share price likely to move
will it be £2 a share again

from yesterdays rns



David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations

[blackvulture] 29/1/2021 10:28

Looks like BGF still selling TR1 tonight hopefully there out.

[hazl] 29/1/2021 09:39

The piece at the base shows the description of the company,though the recent news has thrown them into the limelight.
Plenty more to them and I was watching for a good price before this.

[hazl] 29/1/2021 09:36

3586

You are onto a stick wicket here above surely you sense that?

[hazl] 29/1/2021 09:33

I wanted a gene company anyway so be interesting to see what else they innovate.